CAS 372198-49-7

Fórmula: C8H6ClNO2S

InChI: InChI=1S/C8H6ClNO2S/c1-6-2-3-7(5-10)4-8(6)13(9,11)12/h2-4H,1H3

Clave InChI: HDCNLHWRDPSBDB-UHFFFAOYSA-N

SMILES: CC1=C(C=C(C=C1)C#N)S(=O)(=O)Cl

5-Cyano-2-methyl-benzenesulfonylchloride

CAS: 372198-49-7

Fórmula: C₈H₆ClNO₂S

Pureza: 98%

Forma y color: Solid

Peso molecular: 215.6567

Ref: IN-DA01AIHT

5-Cyano-2-methyl-benzenesulfonylchloride

CAS: 372198-49-7

5-Cyano-2-methyl-benzenesulfonylchloride

Fórmula: C₈H₆ClNO₂S

Pureza: 98%

Peso molecular: 215.66

Ref: 54-OR77441

5-Cyano-2-methylbenzenesulfonyl chloride

CAS: 372198-49-7

Fórmula: C₈H₆ClNO₂S

Pureza: 98%

Forma y color: Solid

Peso molecular: 215.65

Ref: 10-F544435

5-Cyano-2-methylbenzenesulfonyl chloride

CAS: 372198-49-7

5-Cyano-2-methylbenzenesulfonyl chloride

Fórmula: C₈H₆ClNO₂S

Pureza: 97%

Peso molecular: 215.66

Ref: IN-DG00805576

5-cyano-2-methylbenzene-1-sulfonyl chloride

CAS: 372198-49-7

5-cyano-2-methylbenzene-1-sulfonyl chloride (CMS) is a potent and selective inhibitor of the mammalian protein kinase, PI3K. It has been shown to inhibit tumour growth in xenograft models. CMS is able to target human tumours without affecting normal cells, as it does not affect proliferation of human erythrocytes or other cell lines. Furthermore, this drug has been shown to inhibit the growth of tumour cell lines in culture and induce apoptosis in human tumour cells. The selectivity of CMS may be due to its ability to bind only to the phenyl ring portion of the enzyme's substrate.

Fórmula: C₈H₆ClNO₂S

Pureza: Min. 95%

Peso molecular: 215.65 g/mol

Ref: 3D-XPA19849